Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1039/week)
Manufacturing
(505/week)
Technology
(1028/week)
Energy
(395/week)
Other Manufacturing
(322/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Imprimis Pharmaceuticals Inc.
May 30, 2019
Novel Drug Solutions, LLC and Eye Care Northwest, PA Terminates Agreement with Harrow Health, Inc.
Aug 06, 2018
Imprimis Pharmaceuticals Announces Second Quarter 2018 Results
Jul 18, 2018
Imprimis Pharmaceuticals to Present at the Canaccord Genuity 38th Annual Growth Conference on August 9, 2018
May 15, 2018
Imprimis Pharmaceuticals Announces First Quarter 2018 Results
Apr 10, 2018
Imprimis Pharmaceuticals to feature its patent-pending cyclosporine/chondroitin sulfate and patented non-opioid MKO Melt® (midazolam/ketamine/ondansetron) formulations at the upcoming Cataract & Refractive Surgery Medical Meeting
Mar 27, 2018
Imprimis Pharmaceuticals Issued Composition Patent for Non-Opioid Conscious Sedation Formulation
Mar 08, 2018
Imprimis Pharmaceuticals Announces Fourth Quarter 2017 Results
Mar 07, 2018
Imprimis Pharmaceuticals to Present at 30th Annual ROTH Conference on March 13, 2018
Feb 15, 2018
Imprimis Pharmaceuticals to Host its Fourth Quarter 2017 Financial Report Conference Call and Webcast on March 8, 2018 at 4:30 p.m. EST
Jan 30, 2018
Imprimis Pharmaceuticals Now Making Available Two Glaucoma Drugs on FDA's Drug Shortage List
Nov 14, 2017
Imprimis Pharmaceuticals Announces Third Quarter 2017 Results
Oct 31, 2017
Imprimis Pharmaceuticals to Host its Third Quarter 2017 Financial Report Conference Call and Webcast on November 14, 2017 at 4:15 p.m. EST
Oct 24, 2017
Imprimis Launches Surface Pharmaceuticals Subsidiary
Oct 19, 2017
Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restasis®
Sep 14, 2017
FDA Curcumin Investigation Supports Imprimis Statement
Sep 11, 2017
Imprimis Releases Statement Regarding Allergan Lawsuit
Sep 07, 2017
Allergan Files Suits Against Imprimis Pharmaceuticals, Inc., Prescriber's Choice, Inc., and Sincerus Florida, LLC
Aug 10, 2017
Imprimis Pharmaceuticals Announces Second Quarter 2017 Financial Results
Aug 07, 2017
Imprimis Statement Regarding Curcumin Emulsion FDA MedWatch Notice
Jul 31, 2017
Imprimis Pharmaceuticals to Host its Second Quarter 2017 Financial Report Conference Call and Webcast on August 10, 2017 at 4:15 p.m. EDT
Page 1
››
Latest News
Sep 1, 2025
Global Supercapacitors Market Report 2026-2036, with Profiles of 45 Leading Supercapacitor Companies -...
Sep 1, 2025
Force Factor Kicks Off TikTok Shop Super Brand Day with Hair Health Spotlight and Charitable Cut-A-Thon
Sep 1, 2025
Humanoid robots gain momentum, but hardware costs hold back mass adoption, says DIGITIMES
Sep 1, 2025
mindZvue Names Salesforce Pioneer Vinay Chaturvedi as CEO to Drive Global Growth and Digital Transformation
Sep 1, 2025
Tarzan Roars in Times Square: Gorilla's Sad Eyes Deliver Urgent Call to Save the Species
Sep 1, 2025
Valor and Patriotism in China: How Heroic Spirits Endure
Sep 1, 2025
Modoc AI's FeverCoach Surpasses 100,000 Downloads, Reaches Top Ranking in Parenting Apps Abroad
Sep 1, 2025
Norma Completes Quantum AI Algorithm Validation on NVIDIA
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events